Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1159

1.

Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?

Busch MP.

Transfus Clin Biol. 2004 Feb;11(1):26-32. Review.

PMID:
14980546
[PubMed - indexed for MEDLINE]
2.

New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.

Kuhns MC, Busch MP.

Mol Diagn Ther. 2006;10(2):77-91. Review.

PMID:
16669606
[PubMed - indexed for MEDLINE]
3.

Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.

Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA.

Transfusion. 2005 Aug;45(8):1247-57.

PMID:
16078909
[PubMed - indexed for MEDLINE]
4.

Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.

Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP; REDS Study Group.

Transfusion. 2004 Sep;44(9):1332-9.

PMID:
15318857
[PubMed - indexed for MEDLINE]
5.

Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?

Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY.

Transfusion. 2012 Feb;52(2):440-6. doi: 10.1111/j.1537-2995.2011.03283.x. Epub 2011 Aug 2.

PMID:
21810101
[PubMed - indexed for MEDLINE]
6.

Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.

Shang G, Yan Y, Yang B, Shao C, Wang F, Li Q, Seed CR.

Transfus Apher Sci. 2009 Aug;41(1):3-7. doi: 10.1016/j.transci.2009.05.001. Epub 2009 May 31.

PMID:
19487161
[PubMed - indexed for MEDLINE]
7.

Occult hepatitis B virus infection.

Allain JP.

Transfus Clin Biol. 2004 Feb;11(1):18-25. Review.

PMID:
14980545
[PubMed - indexed for MEDLINE]
8.

Detection of an acute asymptomatic HBsAg negative hepatitis B virus infection in a blood donor by HBV DNA testing.

Weber B, Mühlbacher A, Melchior W.

J Clin Virol. 2005 Jan;32(1):67-70.

PMID:
15572009
[PubMed - indexed for MEDLINE]
9.

Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations.

Bouchardeau F, Girault A, Razer A, Servant-Delmas A, Mercier M, Laperche S.

Transfusion. 2006 Dec;46(12):2047-52.

PMID:
17176315
[PubMed - indexed for MEDLINE]
10.

NAT for HBV and anti-HBc testing increase blood safety.

Roth WK, Weber M, Petersen D, Drosten C, Buhr S, Sireis W, Weichert W, Hedges D, Seifried E.

Transfusion. 2002 Jul;42(7):869-75.

PMID:
12375659
[PubMed - indexed for MEDLINE]
11.

Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT.

Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M; Polish Blood Transfusion Service Viral Study Group.

Hepatology. 2006 Dec;44(6):1666-74.

PMID:
17133474
[PubMed - indexed for MEDLINE]
12.

Occult hepatitis B virus infection: implications in transfusion.

Allain JP.

Vox Sang. 2004 Feb;86(2):83-91. Review.

PMID:
15023176
[PubMed - indexed for MEDLINE]
13.

Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.

Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K.

Transfusion. 2007 Jul;47(7):1197-205.

PMID:
17581154
[PubMed - indexed for MEDLINE]
14.

Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT.

Liu CJ, Chen DS, Chen PJ.

J Clin Virol. 2006 May;36 Suppl 1:S33-44. Review.

PMID:
16831692
[PubMed - indexed for MEDLINE]
15.

High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.

Mine H, Emura H, Miyamoto M, Tomono T, Minegishi K, Murokawa H, Yamanaka R, Yoshikawa A, Nishioka K; Japanese Red Cross NAT Research Group.

J Virol Methods. 2003 Sep;112(1-2):145-51.

PMID:
12951223
[PubMed - indexed for MEDLINE]
16.

Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain.

González R, Torres P, Castro E, Barbolla L, Candotti D, Koppelman M, Zaaijer HL, Lelie N, Allain JP, Echevarría JM.

Transfusion. 2010 Jan;50(1):221-30. doi: 10.1111/j.1537-2995.2009.02343.x. Epub 2009 Aug 4.

PMID:
19682332
[PubMed - indexed for MEDLINE]
17.

Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.

Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong YL, Nichols D, Ziermann R, Ness P, Nelson KE.

Transfusion. 2007 Oct;47(10):1803-8.

PMID:
17880604
[PubMed - indexed for MEDLINE]
18.

Low-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor.

Dreier J, Kröger M, Diekmann J, Götting C, Kleesiek K.

Transfus Med. 2004 Apr;14(2):97-103.

PMID:
15113374
[PubMed - indexed for MEDLINE]
19.

Hepatitis B virus blood screening: unfinished agendas.

Comanor L, Holland P.

Vox Sang. 2006 Jul;91(1):1-12. Review. Erratum in: Vox Sang. 2007 Apr;92(3):278.

PMID:
16756595
[PubMed - indexed for MEDLINE]
20.

Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.

Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R.

Transfusion. 2009 Jun;49(6):1115-25. doi: 10.1111/j.1537-2995.2009.02110.x. Epub 2009 Feb 27.

PMID:
19309474
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk